Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Acerus Pharmaceuticals Corporation market cap is $37.5M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Acerus Pharmaceuticals Corporation 52 week high is $0.35 as of April 25, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Acerus Pharmaceuticals Corporation 52 week low is $0.105 as of April 25, 2024.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Acerus Pharmaceuticals Corporation’s P/E ratio is None.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Acerus Pharmaceuticals Corporation P/B ratio is -26.0323.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Acerus Pharmaceuticals Corporation's EBITDA is -4.14.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Acerus Pharmaceuticals Corporation 50-day moving average is $0.1572.
Acerus Pharmaceuticals Corporation has 29 employees.